Healthcare & Pharmaceuticals Blog
- Blog: Haynes and Boone BlogsWorking Draft Distributed to Members of Well-Known Standard Setting Group Was Not a PublicationPosted on July 23, 2019 by Vinu RajIn Samsung Electronics Co., Ltd. v. Infobridge Pte. Ltd., the Court of Appeals for the Federal Circuit (“the CAFC”) addressed the legal standard for assessing the public accessibility of prior art documents before a patent’s critical date. Appeal No. 18-2007 (Fed. Cir. July 12, 2019). This case arises from an appeal by Samsung to decisions […] The post Working Draft Distributed to Members of Well-Known Standard Setting Group Was Not a Publication appeared first on Haynes and Boone Blogs.
- Blog: Homeostasis: Dykema's Health Care Law BlogNew Development: Government Authority to Dismiss Qui Tam ActionsPosted on July 23, 2019 by Jonathan S. FeldThe False Claims Act grants the government the authority to dismiss qui tam actions over the objections of the relator if “the court has provided the person with an opportunity for a hearing on the motion.” 31 USCS § 3730. However, what constitutes a “hearing” under the Act and the extent of the government’s authority to unilaterally dismiss qui tam actions has been the subject of dispute amongst the Courts of Appeals. Read More › Tags:
- Blog: Waller Law BlogFlorida, Georgia changes to certificate of need (CON) laws are biggest in SoutheastPosted on July 21, 2019 by Kim Harvey Looney,Zachary D. Trotter
- Blog: Biologics BlogFederal Circuit Invalidates Polynucleotide-Labeling Claims for Lack of EnablementPosted on July 15, 2019 by In Enzo Life Sciences v. Roche Molecular Systems, No. 2017-2498, 2017-2499, 2017-2545, 2017-2546, Slip op. (Fed. Cir. July 5, 2019), the Federal Circuit affirmed summary judgment of invalidity for lack of enablement of Enzo’s two patents relating to non-radioactive labeling of polynucleotides. The decision highlights non-enablement issues that may arise with respect to broad functional [...]
- Blog: EndpointsExperienced Health Care and Privacy Partner Join’s Verrill Dana’s Health Care GroupPosted on December 13, 2018 by Academic and Clinical Research GroupWe are pleased to welcome attorney Nadine Peters to our nationally-recognized Health Care Group. Nadine comes to Verrill Dana with more than 15 years of experience as a health care and privacy attorney and focuses on clients within the health care and life sciences industries. Most recently, Nadine served as Deputy General Counsel at the Patient-Centered Outcomes Research Institute (PCORI), an independent non-profit organization authorized under the Affordable Care Act to fund comparative effectiveness research. Prior to PCORI, she was [...]